Literature DB >> 19169062

Prognostic factors in patients with papillary thyroid carcinoma.

O Soyluk1, F Selcukbiricik, Y Erbil, A Bozbora, Y Kapran, N Ozbey.   

Abstract

BACKGROUND: Papillary thyroid carcinomas are associated with metastases and decreased survival in a small group of patients. AIM: The aim of this study is to determine the factors associated with recurrences/metastases in papillary thyroid carcinoma patients. SUBJECTS AND METHODS: One hundred and thirty-one patients with papillary thyroid carcinoma were evaluated retrospectively. The diagnosis was papillary microcarcinoma (PMC) in 48 patients. All patients had undergone near-total/total thyroidectomy. Radioactive iodine was given to 103 patients. Age at diagnosis, gender, previous history of thyroid disease, tumor stage, histopathological characteristics of tumor and initial treatment strategies were evaluated.
RESULTS: Recurrences/metastases developed in 17 patients during follow-up. Recurrences developed at a significantly higher percentage in patients with a tumor stage >T1 and patients with lymph node metastasis at presentation. No significant difference was observed in recurrence ratio between patients with PMC and patients with a tumor diameter > or =1cm. In the Cox-regression analysis only the advanced tumor stage (>T1) and presence of lymph node metastases were found to be significant predictors for recurrence (univariate analysis, odds ratio =4.02 and 3.15, respectively). However, multivariate analysis did not reveal any significant independent predictors. According to the Kaplan- Meier survival analysis, lymph node metastases at presentation were associated with a decrease in recurrence-free survival at statistical significance (p=0.05). No mortality was observed during follow-up.
CONCLUSION: Papillary thyroid carcinoma leads to recurrences/metastases in a small group of patients. Initial characteristics of the patients--i.e. presence of lymph node metastases--may predict recurrences/metastases in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 19169062     DOI: 10.1007/BF03345644

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

Review 1.  Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; R T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

2.  Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas.

Authors:  Agnès Rouxel; Gilles Hejblum; Marie-Odile Bernier; Pierre-Yves Boëlle; Fabrice Ménégaux; George Mansour; Catherine Hoang; André Aurengo; Laurence Leenhardt
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

3.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

Review 4.  Papillary and follicular thyroid carcinoma.

Authors:  M J Schlumberger
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

5.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

6.  [Significance of lymph node metastases in differentiated thyroid carcinoma].

Authors:  H Lerch; H B Saur; O Schober
Journal:  Nuklearmedizin       Date:  1995-10       Impact factor: 1.379

7.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

8.  Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer.

Authors:  M C Coburn; H J Wanebo
Journal:  Am J Surg       Date:  1992-12       Impact factor: 2.565

9.  Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.

Authors:  C Passler; C Scheuba; G Prager; K Kaczirek; K Kaserer; G Zettinig; B Niederle
Journal:  Endocr Relat Cancer       Date:  2004-03       Impact factor: 5.678

10.  Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway.

Authors:  L A Akslen; T Haldorsen; S O Thoresen; E Glattre
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

View more
  3 in total

1.  Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery. Comparison with a control group.

Authors:  Luis García-Pascual; Montserrat Balsells; Matteo Fabbi; Carlos Del Pozo; María-Teresa Valverde; Jaume Casalots; José-Manuel González-González; Enrique Veloso; Jordi Anglada-Barceló
Journal:  Endocrine       Date:  2011-05-04       Impact factor: 3.633

Review 2.  Pancreatic metastasis of papillary thyroid carcinoma: a case report with review of the literature.

Authors:  Xiao-Ou Li; Zheng-Peng Li; Ping Wang; Cheng-Lin Li; Ji-Hua Wu; Jian-Zhong Zhang; Yan Cui
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

3.  Prognostic values of thyroid tumours.

Authors:  Suzana Manxhuka-Kerliu; Emine Devolli-Disha; Arsim Gerxhaliu; Halil Ahmetaj; Arijeta Baruti; Sadushe Loxha; Hajdin Thaqi
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.